What's Happening
Reprogramming Somatic Cells – Down to One Gene!
- Published on Dec 13, 2010
From Cell Stem CellA new study from the lab of Sheng Ding (The Scripps Research Institute), published recently in Cell Stem Cell, reports the reprogramming of human primary somatic cells using only OCT4 gene transduction and a combination of small molecules. Kim et al had previously shown than one factor reprogramming is possible, but in human foetal neural stem cells, a cell source perhaps not readily available. iPSCs were generated at an efficiency of roughly 1 colony in 250,000 target cells over an 8...
Phosphorylation of Sox2 Cooperates in Reprogramming to Pluripotent Stem Cells
- Published on Dec 13, 2010
From the December Issue of Stem CellsBy Stuart P AtkinsonModifications of histone proteins have been well studied in ESCs and iPSCs and we are beginning to understand the importance that these modifications have in relation to chromatin structure and gene regulation and indeed the enzymes which mediate these modifications. However, research into modifications of non-histone proteins in pluripotent cells has perhaps lagged behind. Studies in 2009 Saxe et al, Swaney et al and Van Hoof et al) have...
STEM CELLS' Position Statement on hESC Research
- Published on Aug 27, 2010
Durham, North Carolina, August 27, 2010 — The Journal STEM CELLS® has published many important and exciting achievements in the field of stem cells during its twenty-eight year history.
AlphaMed Press awarded CEO Cancer Gold StandardTM accreditation
- Published on May 28, 2010
DURHAM, NC (May 21, 2010) – AlphaMed Press has received CEO Cancer Gold Standard™ accreditation, recognizing the organization’s commitment to taking concrete actions to reduce the cancer risk of its employees and their families through screenings, early detection, and healthy changes in lifestyle and in the workplace.
NEW PRESS RELEASE: Stem Cells Which “Fool Immune System” May Provide Vaccination for Cancer
- Published on Oct 12, 2009
North Carolina, October, 2009 – Scientists from the United States and China have revealed the potential for human stem cells to provide a vaccination against colon cancer, reports a study published in STEM CELLS.






